Targeting dopamine receptor 2 (DRD2) signaling in combination with temozolomide chemotherapy as a novel therapeutic concept in glioblastomas. | |
Johannessen, Tor-Christian Aase; Grudic, Amra; Zhu, Huaiyang; Saed, Halala; Varughese, Jobin; Yang, Ning; Sundstrom, Terje; Janji, Bassa 更多 | |
2015 | |
会议名称 | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer |
会议日期 | MAY 29-JUN 02, 2015 |
卷号 | 33 |
期号 | 15 |
收录类别 | CPCI-S ; SCIE |
会议录 | JOURNAL OF CLINICAL ONCOLOGY |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6035940 |
专题 | 山东大学 |
作者单位 | 1.[Johannessen, TCA 2.Grudic, A 3.Zhu, HY 4.Saed, H 5.Varughese, J 6.Yang, N 7.Sundstrom, T 8.Janji, B 9.Wang, J 10.Lund-Johansen, M |
推荐引用方式 GB/T 7714 | Johannessen, Tor-Christian Aase,Grudic, Amra,Zhu, Huaiyang,et al. Targeting dopamine receptor 2 (DRD2) signaling in combination with temozolomide chemotherapy as a novel therapeutic concept in glioblastomas.[C]. 见:Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer. MAY 29-JUN 02, 2015. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论